| 发明名称 | Composition and method for determination of CK19 expression | ||
| 摘要 | Disclosed is a method for quantitative determination of CK-19 mRNA positive cells in a biological sample. The method can be used, for instance, with peripheral blood to detect cancer in a patient. In one embodiment, the method can be used to detect the cancer before initiation of adjuvant treatment, thereby providing information about therapeutic efficacy. Practice of the invention method is sensitive, reliable, and easy to perform. | ||
| 申请公布号 | US9593374(B2) | 申请公布日期 | 2017.03.14 |
| 申请号 | US201314031051 | 申请日期 | 2013.09.19 |
| 申请人 | Evriklia Lianidou;Stathopoulou Aliki;Mavroudis Dimitrios;Georgoulias Vasileios | 发明人 | Evriklia Lianidou;Stathopoulou Aliki;Mavroudis Dimitrios;Georgoulias Vasileios |
| 分类号 | C12Q1/68;C07H21/04 | 主分类号 | C12Q1/68 |
| 代理机构 | Loza & Loza, LLP | 代理人 | Fedrick Michael F.;Loza & Loza, LLP |
| 主权项 | 1. A primer pair consisting of one primer having the sequence of SEQ ID NO: 1 and one primer having the sequence of SEQ ID NO: 2. | ||
| 地址 | Athens GR | ||